This month, in April, the International Diabetes Federation formally recognized a new, distinct form of the disease: type 5 ...
UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...
Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.
More than 1 in 10 Americans have diabetes—that’s a lot of people. But diabetes isn’t just one universal condition. There are many different types. All types involve problems with blood sugar ...
It's a running joke that a cure for type 1 diabetes is only five years away and has been for 50 years, but new stem cell trials and immune drugs hint that we're closer than ever to a functional cure ...
Add Yahoo as a preferred source to see more of our stories on Google. While nearly 40 million people in the US suffer from diabetes, some 8.7 million of them don’t even know they have the condition, ...
New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...
David Novak and his late wife Wendy — who died from Type 1 diabetes complications in 2024 — spent their lives advocating for ...
Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some individuals with type 1 diabetes experience cognitive differences, sometimes ...
Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...
Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...
Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...